Jupiter Wellness, Inc. (JUPW) Stock Analysis

Jupiter Wellness, Inc. (JUPW) Healthcare & Pipeline Overview

Jupiter Wellness, Inc. develops and commercializes cannabidiol (CBD)-based therapeutics and wellness products, targeting dermatological conditions and general wellness. With a focus on prescription and over-the-counter solutions, the company operates in the competitive specialty and generic drug manufacturing sector, emphasizing innovation in CBD applications.

What Is the Investment Thesis for JUPW?

Jupiter Wellness, Inc. presents a speculative investment opportunity in the emerging CBD-based therapeutics and wellness market. The company's clinical pipeline, including CaniDermRX (JW-100), JW-101, and JW-200, represents potential value drivers, contingent on successful clinical trials and regulatory approvals. The current market capitalization of $49.3M reflects the early stage and inherent risks associated with the company. Revenue growth will depend on the successful commercialization of both prescription and consumer products. A key risk is the company's negative profit margin of -1703.6% and gross margin of -1.3%, indicating significant challenges in achieving profitability. The company's beta of 0.28 suggests lower volatility compared to the overall market. Investors should closely monitor clinical trial outcomes, regulatory milestones, and the company's ability to improve its financial performance.

Based on FMP financials and quantitative analysis

JUPW Key Highlights

Market Cap of $49.3M reflects its small size and early stage in the CBD-based therapeutics market.

• P/E ratio of -0.30 indicates the company is currently not profitable.
• Profit Margin of -1703.6% highlights significant challenges in achieving profitability.
• Gross Margin of -1.3% suggests difficulties in covering the cost of goods sold.
• Beta of 0.28 indicates lower volatility compared to the overall market.

Who Are JUPW's Competitors?

JUPW is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are JUPW's Key Strengths?

Proprietary CBD-based formulations

• Clinical pipeline targeting unmet medical needs
• Established brand in CBD-infused consumer products
• Experienced management team

What Are JUPW's Weaknesses?

Limited financial resources

• Negative profit and gross margins
• Dependence on regulatory approvals
• Small number of employees

What Could Drive JUPW Stock Higher?

JUPW catalyst: Clinical trial results for CaniDermRX (JW-100) in the treatment of eczema, dermatitis, and actinic keratosis.

• FDA approval for JW-101 as a prescription product for the treatment of burns.
• Expansion of distribution channels for CaniSun and CaniSkin consumer products.
• Development of new CBD-infused product formulations.
• Strategic partnerships with established pharmaceutical and wellness companies.

What Are the Key Risks for JUPW?

Regulatory changes impacting the legality and marketability of CBD products.

• Negative clinical trial results for key therapeutic candidates.
• Competition from larger pharmaceutical companies and other CBD product manufacturers.
• Adverse effects of CBD impacting consumer demand.
• Limited financial resources hindering research and development efforts.

What Are the Growth Opportunities for JUPW?

• Expansion of CaniDermRX Product Line: Jupiter Wellness has the opportunity to expand its CaniDermRX product line to address a broader range of dermatological conditions. The global market for dermatology treatments is projected to reach $36.6 billion by 2027. Successful clinical trials and regulatory approvals for new CaniDermRX formulations could drive significant revenue growth. The timeline for this growth opportunity is dependent on the progress of clinical trials and regulatory processes, with potential for commercialization within the next 3-5 years.
• Commercialization of JW-101 for Burn Treatment: The development and commercialization of JW-101 as a prescription product for the treatment of burns represents a significant growth opportunity. The global market for burn care products is estimated at $2.9 billion. Positive clinical trial results and FDA approval could lead to substantial revenue generation. The timeline for this opportunity is contingent on clinical trial outcomes and regulatory approval, potentially materializing within the next 3-5 years.
• Growth in CBD-Infused Consumer Products: Jupiter Wellness can capitalize on the growing market for CBD-infused consumer products through its CaniSun and CaniSkin brands. The global CBD market is projected to reach $55.8 billion by 2028. Expanding distribution channels and introducing new product formulations could drive increased sales. This growth opportunity can be realized in the short term, with ongoing product development and marketing efforts.
• Strategic Partnerships and Licensing Agreements: Jupiter Wellness can pursue strategic partnerships and licensing agreements to expand its product portfolio and market reach. Collaborating with established pharmaceutical companies or wellness brands could provide access to new markets and distribution channels. The timeline for this opportunity is dependent on identifying and securing suitable partnerships, with potential for agreements to be established within the next 1-2 years.
• International Expansion: Jupiter Wellness has the opportunity to expand its operations into international markets, particularly in Europe and Asia, where there is growing demand for CBD-based products. Adapting its product formulations and marketing strategies to meet local regulations and consumer preferences will be crucial for success. This growth opportunity can be pursued in the medium to long term, with market entry strategies potentially implemented within the next 3-5 years.

What Are JUPW's Competitive Advantages?

• Proprietary CBD-based formulations.
• Clinical pipeline of potential prescription therapeutics.
• Established brand recognition in the CBD-infused consumer product market.
• Intellectual property protection through patents and trademarks.

What Does JUPW Do?

Jupiter Wellness, Inc., formerly known as CBD Brands, Inc., was founded in 2018 and is headquartered in Jupiter, Florida. The company is dedicated to the development of cannabidiol (CBD) based medical therapeutics and wellness products. Jupiter Wellness is focused on creating solutions for unmet needs in the dermatological and wellness markets. Their clinical pipeline includes CaniDermRX (JW-100), a topical formulation containing CBD and aspartame intended for the treatment of eczema, dermatitis, and actinic keratosis. Additionally, JW-101 is being developed as a prescription product for burn treatment, and JW-200 is a non-prescription lotion/lip balm targeting cold sore symptoms. Beyond prescription therapeutics, Jupiter Wellness manufactures, distributes, and markets a range of consumer products. These include CBD-infused sunscreen under the CaniSun brand, CBD-infused skin care lotion under the CaniSkin brand, and products for dermatological treatments of pain and inflammation under the CaniDermRX brand. The company's strategy involves both prescription and over-the-counter products to capture a broader market and provide various CBD-based solutions. Jupiter Wellness aims to establish itself as a key player in the emerging market for CBD-based medical and wellness products, leveraging its research and development efforts to create differentiated and effective solutions.

What Products and Services Does JUPW Offer?

• Develops CBD-based medical therapeutics.
• Creates wellness products infused with CBD.
• Focuses on treatments for dermatological conditions like eczema and dermatitis.
• Develops prescription products for burns.
• Manufactures and distributes CBD-infused sunscreen.
• Markets CBD-infused skin care lotions.
• Creates products for pain and inflammation relief.

How Does JUPW Make Money?

• Develops and patents novel CBD-based formulations.
• Conducts clinical trials to validate the efficacy of its therapeutics.
• Manufactures and distributes consumer wellness products.
• Generates revenue through sales of prescription and over-the-counter products.

What Industry Does JUPW Operate In?

Jupiter Wellness operates within the Drug Manufacturers - Specialty & Generic industry, which is experiencing growth driven by increasing demand for specialized treatments and generic alternatives. The market for CBD-based products is expanding, but faces regulatory uncertainties and competition from established pharmaceutical companies and other CBD product manufacturers. The company's success depends on its ability to navigate regulatory hurdles, develop effective products, and establish a strong market presence. Competitors include companies like Alvogen (ALVR) and Blue Water Vaccines (BLUE), which are also focused on developing and marketing specialized pharmaceutical products.

Who Are JUPW's Key Customers?

• Individuals seeking treatment for dermatological conditions.
• Patients requiring burn treatment.
• Consumers interested in CBD-infused wellness products.
• Retailers and distributors of wellness and skincare products.

Company Profile

Jupiter Wellness, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Jupiter, US. The company is led by CEO Brian Scott John. JUPW has traded publicly since 2020.

JUPW Valuation & Market Position

With a $49.3M market cap, Jupiter Wellness, Inc. sits in the micro-cap segment of the market.

Jupiter Wellness, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile.

JUPW Financials

JUPW Latest News

No recent news available for JUPW.

JUPW Healthcare Stock FAQ

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources